← Insider buys
DCPH

Deciphera Pharmaceuticals, Inc.

Director Michael Douglas Taylor sold $2.8M of Deciphera Pharmaceuticals, Inc.

Sold$2,817,558
$37.57Price
75,000Shares
−100%Stake

What DCPH did after the filing

Prices for DCPH after this filing aren't in yet.

Traded Wed, Apr 1. Filed Fri, Apr 3, 12:10 PM ET, during the session. Not investment advice.